Giant Biogene (02367.HK) Announces Interim Results, Adjusted Net Profit Approximately RMB 945.5 Million, Down 21.5% Year-on-Year

Zhito Finance APP news, Giant Biogene (02367.HK) announced its 2026 interim results, with revenue of approximately RMB 2.918 billion, a year-on-year decrease of 6.3%; gross profit of approximately RMB 2.318 billion, a year-on-year decrease of 8.8%; profit attributable to equity shareholders of the company of approximately RMB 940 million, a year-on-year decrease of 20.5%; adjusted net profit of approximately RMB 945.5 million, a year-on-year decrease of 21.5%; basic earnings per share of RMB 0.89.